First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease.
Takahashi K, Uchida M, Kato G, Takamori A, Kinoshita T, Yoshida M, Tajiri R, Kojima K, Inoue H, Kobayashi H, Sadamatsu H, Tashiro H, Tanaka M, Hayashi S, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T; Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group.
Takahashi K, et al. Among authors: inoue h.
Int J Chron Obstruct Pulmon Dis. 2020 Sep 14;15:2115-2126. doi: 10.2147/COPD.S268905. eCollection 2020.
Int J Chron Obstruct Pulmon Dis. 2020.
PMID: 32982204
Free PMC article.
Clinical Trial.